-
-
-
-
-
-
-
Revelation Biosciences forms advisory board for kidney injury trial
-
-
-
-
-
-
-
Revelation Biosciences implements 1-for-4 reverse stock split
-
-
-
-
-
-
-
Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date
-
-
-
-
-
-
-
Revelation Biosciences schedules webcast to discuss Phase 1b data
-
-
-
-
-
-
-
Revelation Biosciences (REVB) Misses Q1 EPS by 211c
-
-
-
-
-
-
-
Roth/MKM Reiterates Buy Rating on Revere Bank (REVB)
-
427,067 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

